Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-20-062733

Director sold 800,000 shares at an average $100.81 ($80,650,635)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ultragenyx Pharmaceutical Inc. Director 2020-12-08 Sale −442,255 $105.54 $46,675,593 2,557,745 D
Ultragenyx Pharmaceutical Inc. Director 2020-12-09 Sale −357,745 $94.97 $33,975,043 2,200,000 D
Open-market sales · 800,000 sh · avg $100.81 · $80,650,635
Loading xslF345X03/doc4.xml…